
Will Casgevy, the first cell therapy using CRISPR gene editing, have net sales >$100M in 2024?
8
110Ṁ330resolved Feb 16
Resolved
NO1H
6H
1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
🏅 Top traders
# | Name | Total profit |
---|---|---|
1 | Ṁ43 | |
2 | Ṁ26 | |
3 | Ṁ4 | |
4 | Ṁ0 | |
5 | Ṁ0 |
People are also trading
Related questions
Will a gene therapy that edits multiple genes using CRISPR be approved by the FDA before 2030?
78% chance
Will a CRISPR-based gene editing therapy for transthyretin (ATTR) amyloidosis be available in the US by 2027?
59% chance
Will there be an in-vivo gene therapy that edits multiple genes at once approved anywhere in the world before 2030?
52% chance
Which applications of CRISPR technology will achieve regulatory approval for use in humans by 2030?
Will I receive any kind of gene therapy created using CRISPR before I die?
66% chance
Will any CRISPR based gene drive be released in the wild by 1/1/2026?
15% chance
Will Cerebras get more than 100% year-to-year growth between 2024 and 2025?
45% chance
Will Cytokinetics agree to be acquired by the end of 2025?
22% chance
Will anyone use the compbio platforms ViaScientific or Bigomics for their Regeneron STS project in 2025?
50% chance
Will we have gene therapy for a major strain of Crohn's disease by 2030?
26% chance